Search Results 731-740 of 18356 for Hepatitis C

  1. David C. Weber, M.D. - Doctors and Medical Staff - Mayo Clinic

    Education · 1992. ResidentPhysical Medicine and Rehabilitation, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine.

  2. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    Participants seropositive for HBV with undetectable HBV DNA by PCR are permitted with appropriate antiviral prophylaxis. * Negative test results for hepatitis C ...

  3. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    * Positive test for hepatitis C RNA (a subject who is hepatitis C virus \[HCV\] antibody positive but HCV RNA negative due to documented, curative prior ...

  4. Liver transplant - Doctors & Departments - Mayo Clinic

    Autoimmune hepatitis · Cholangiocarcinoma (bile duct cancer) · Cirrhosis · Esophageal varices · Hepatic encephalopathy · Hepatitis B · Hepatitis C ...

  5. COVID-19: Who's at higher risk of serious symptoms? - Mayo Clinic

    Chronic liver disease, specifically cirrhosis, nonalcoholic fatty liver disease, alcoholic liver disease and autoimmune hepatitis. HIV not well managed with ...

  6. Maraviroc (oral route) - Side effects & dosage - Mayo Clinic

    Make sure you tell your doctor if you have any other medical problems, especially: Heart disease or; Liver problems (eg, hepatitis B or C), history of or ...

  7. A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders - Mayo Clinic

    Eculizumab. History of Hepatitis B and/or Hepatitis C (Hep B/C at screening); Known history of a primary immunodeficiency (congenital or acquired) or an ...

  8. A Study Evaluating AMG 424 in Subjects With Multiple Myeloma - Mayo Clinic

    Positive Hepatitis C virus antibody (HepCAb): hepatitis C virus RNA by PCR is necessary. Detectable hepatitis C virus RNA suggests chronic hepatitis C.

  9. MAGNITUDE: a Phase 3 Study of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM) - Mayo Clinic

    * Has hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection * History of active malignancy within 3 years prior to screening * RNA ...

  10. Study Investigating the Activity of Vidofludimus Calcium as a Treatment for Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

    Active hepatitis A or B infection. Active hepatitis C infection (antibody positive); patients with a history of hepatitis C infection will be eligible for ...